Board

Inge Marie Svane

Director, Professor, MD, PhD
National Center for Cancer Immune Therapy - CCIT-DK
Dept. of Oncology 
Herlev and Gentofte Hospital
Borgmester Ib Juuls Vej 25 C, 5.
DK-2730 Herlev
e-mail: inge.marie.svane@regionh.dk
phone: +45 38 68 21 31

Field of research:
Main focus areas are melanoma and cancer immunology and therapy. Director of Center for Cancer Immune Therapy which has a focus on development of immunological treatment of cancer, and has a research profile based on equally weighted experimental and clinical projects with a tight interconnection. Head of disseminated melanoma treatment in the Capital Region of Denmark.

Stig E. Bojesen

Professor, MD, DrMedSci
Dept. of Clinical Biochemistry
Herlev and Gentofte Hospital
Borgmester Ib Juuls Vej 73
DK-2730 Herlev
e-mail: stig.egil.bojesen@regionh.dk
phone: +45 38 68 38 43

Field of research:
Identification, description, measurement and implementation of blood-based biomarkers of cancer risk and prognosis; mainly proteins and nucleic acids. We do this by studying very large international groups of patients and controls and national population-based cohorts of the general population.

Maja Charlotte Dittmar

MD, PhD student
Rigshospitalet, Copenhagen University Hospital
Dept. of Paediatrics and Adolescent Medicine
Paediatric Oncology Research Laboratory
Blegdamsvej 9
2100 Copenhagen
e-mail: maja.charlotte.dittmar@regionh.dk

Field of research: 
In my PhD, I focus on paediatric sarcoma research, with an emphasis on treatment intensity and maintenance therapy. I work across both clinical and translational studies, including the development of a novel immunomodulatory maintenance strategy (RESIST), the evaluation of treatment patterns and outcomes through nationwide registry-based cohort studies, and the investigation of circulating tumour DNA (ctDNA) as a diagnostic and prognostic biomarker.

Jeppe Friborg

MD, PhD, Associate Professor
Consultant in Clinical Oncology
Rigshospitalet, Copenhagen University Hospital
Department of Oncology
DK-2100 Copenhagen
Phone: +45 35 45 81 89

Field of research:
Clinical research in head and neck cancer, with a particular focus on reducing morbidity associated with radiotherapy. My work involves leading and contributing to national randomized controlled trials, as well as regional and local prospective studies and retrospective analyses utilizing Danish clinical databases.

Cecilie Okholm Hartmann

MD, PhD student
Rigshospitalet, Copenhagen University Hospital
Department of Oncology
Blegdamsvej 9
DK-2100 Copenhagen Ø
Phone: +45 25 11 47 20
e-mail: cecilie.okholm.hartmann@regionh.dk

Field of research:
My PhD project investigates the use of artificial intelligence in radiotherapy planning for patients with breast cancer. Specifically, the project aims to evaluate and implement an AI-based auto-segmentation tool for target delineation in patients undergoing radiotherapy following surgery for breast cancer.

Lisbeth Hölmich

Professor, consultant, DMSc
Department of Plastic Surgery
Herlev and Gentofte Hospital
Borgmester Ib Juulsvej 1
2730 Herlev
University of Copenhagen
e-mail: lisbet.rosenkrantz.hoelmich@regionh.dk
Phone +45 3868 1243

Field of research:
Melanoma and non-melanoma skin cancer; clinical, translational, and register based studies. Special focus on new methods for diagnosis, follow-up and identification of recurrence. Breast reconstruction and breast implant complications, lymphedema, abdominal wall reconstruction a.o.

Julia Sidenius Johansen

Professor, consultant, MD
Dept. of Oncology and dept. of Internal Medicine
Herlev and Gentofte Hospital
Borgmester Ib Juuls Vej 1
2730 Herlev
e-mail: julia.sidenius.johansen@regionh.dk 
phone: +45 38 68 92 41

Field of research:
Translational research with a main interest in new diagnostic, predictive and prognostic biomarkers in patients with colorectal cancer, pancreatic cancer, HCC and cholangiocarcinoma. We have large biobanks and corresponding databases of patients with colorectal cancer, pancreatic cancer and cholangiocarcinoma. New focus areas are better treatments of patients with gastrointestinal cancer and elderly patients. 

Carsten Utoft Niemann

MD, PhD, Associate Professor
Consultant in Hematology:Internal Medicine
Rigshospitalet, Copenhagen University Hospital
Department of Hematology
Blegdamsvej 9, Building 5074
DK-2100 Copenhagen Ø
Web: www.rigshospitalet.dk/CLL-lab
e-mail: carsten.utoft.niemann@regionh.dk
Phone: +45 35 45 88 78

Field of research: 
As a clinical hematologist with laboratory background, my research combine genetic and functional characterization of lymphoid malignant cells and microenvironmental cells, MRD testing and diagnostic work up for lymphoid malignancies into designing clinical trials for precision hematology. This feeds into development of extended decision matrices in lymphoid malignancies based on medical Artificial Intelligence modeling of multidimensional big data for testing in clinical trials, thereby improving precision medicine in lymphoid malignancies and beyond.

Gitte Persson

Consultant, MD, PhD
Associate Research Professor, University of Copenhagen
Department of Oncology
Herlev and Gentofte Hospital
Borgmester Ib Juuls Vej 1
DK-2730 Herlev
Email: gitte.persson.03@regionh.dk
Phone: +45 38 68 92 99

Fields of research:
Clinical research with focus on lung cancer, oligometastases, palliative radiotherapy and multimodality treatment. Bridging between radiophysics and clinical radiotherapy research.

Astrid Hundebøll Torpe 

MD, PhD student
Rigshospitalet, Copenhagen University Hospital
Department of Hematology
Blegdamsvej 9
DK-2100 Copenhagen Ø
Phone: +45 40 96 09 80
e-mail: astrid.hundeboell.torpe@regionh.dk

Field of research:
My research focuses on multiple myeloma and includes real-world evidence, epidemiology, and clinical trials. I am involved in nationwide studies evaluating outcomes and treatment patterns of novel anti-myeloma therapies, as well as large registry-based projects investigating infections and supportive care in patients with multiple myeloma. Furthermore, I am involved in clinical trial research, including Danish investigator-initiated studies, international multicenter trials, and platform trials in multiple myeloma.

Ivan Vogelius

Mette Wassard Yde